Deep-research medication guides, drug safety explainers, and cost-saving resources — written for patients and reviewed by pharmacists.
Wegovy and Zepbound are both FDA-approved injectable medications for weight loss, but Zepbound produces 47% more weight loss in head-to-head trials.
Mounjaro and Zepbound both contain tirzepatide, but are FDA-approved for different conditions. Learn the key differences in indications, cost, insurance coverage, and when to choose each drug.
Ozempic's list price is $997/month without insurance, but the Novo Nordisk savings program offers $199 for new patients and $349/month ongoing. Here is every pricing option for Ozempic without insurance in 2026.
Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus. Brand-name prices range from $997–$1,349/month, but savings programs, NovoCare Pharmacy, and (where still available) compounded semaglutide offer substantial discounts.
Wegovy's list price is $1,349/month, but the Novo Nordisk savings program offers $199/month for new patients and $25/month with commercial insurance coverage. Here is every pricing option for Wegovy without insurance in 2026.
Mounjaro's list price is $1,112/month without insurance, but the Lilly Savings Card, prescription discount services, and patient assistance programs can dramatically reduce what you pay. Here is every option.
Tirzepatide (Mounjaro and Zepbound) costs $1,069–$1,112 per month at list price, but self-pay programs, savings cards, and discount services can reduce that to $299–$499/month. Here is every pricing option explained.
Zepbound's list price is $1,086/month, but Eli Lilly's self-pay vial program cuts that to $299–$449/month. Here is every pricing option for Zepbound without insurance in 2026.
Nearly 3 in 10 Americans skip medications because of cost. This guide covers nine evidence-based strategies — from asking for generics to stacking discount programs — that can reduce your prescription costs by 50–90%.